Most clinical trials of chemotherapeutics for advanced bladder cancer have shown limited benefits, so new prognostic markers and effective treatment strategies are necessary. Yoshino et al. discuss the microRNAs that have been identified as potential oncogenes or tumour suppressors, as well as those that have been implicated as prognostic biomarkers, in bladder cancer.
- Hirofumi Yoshino
- Naohiko Seki
- Hideki Enokida
